🦊/Lists

Biotech Investors & VC Firms in Asia-Pacific

571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.

Regeneration.VC
Redondo BeachSeed–Series B$1M – $3M
9 people
Droia Ventures
LuxembourgPre-Seed–Series B$540K
13 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
21 people
Starship Ventures
San FranciscoPre-Seed–Seed
14 people
New Mountain Capital
New YorkGrowth–Late Stage
6 people
Redesign Health
New YorkSeed–Late Stage
18 people
LYFE Capital
Menlo ParkSeed–Late Stage
16 people
Shastra VC
Pre-Seed–Series A$550K – $12M
8 people
Neva Sgr.
TurinSeries A–Growth
8 people
Shanda Group
Redwood CityPre-Seed–Series A
20 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
Ally Bridge Group
New YorkSeed–Late Stage
7 people
Scientia Ventures
New YorkSeries A–Series B
13 people
Newton Biocapital
BrusselsSeed–Series A
16 people
Version One Ventures
VancouverPre-Seed–Seed$250K – $500K
3 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
7 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
Intermediate Capital Group
LondonGrowth–Late Stage$5M – $50M
16 people
Pivotal Life Sciences
San FranciscoSeed–Late Stage
14 people
Cathay Capital
StamfordGrowth
11 people
Big Basin Capital
CupertinoPre-Seed–Series A$1M
5 people
SABIC Ventures
SittardSeed–Late Stage$500K – $20M
10 people
3B Future Health Fund
MonacoPre-Seed–Late Stage$12M
12 people
Apex Innovative Investments Ventures
VancouverPre-Seed–Series A$250K
9 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.